Parallel Advisors’s Avanos Medical AVNS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.75K | Buy |
125
+62
| +98% | +$835 | ﹤0.01% | 3418 |
|
|
2025
Q4 | $707 | Sell |
63
-320
| -84% | -$3.66K | ﹤0.01% | 3358 |
|
|
2025
Q3 | $4.43K | Sell |
383
-9
| -2% | -$105 | ﹤0.01% | 2833 |
|
|
2025
Q2 | $4.8K | Sell |
392
-841
| -68% | -$10.6K | ﹤0.01% | 2763 |
|
|
2025
Q1 | $17.7K | Buy |
1,233
+857
| +228% | +$13.4K | ﹤0.01% | 2205 |
|
|
2024
Q4 | $5.99K | Buy |
376
+297
| +376% | +$5.88K | ﹤0.01% | 2569 |
|
|
2024
Q3 | $1.9K | Sell |
79
-14
| -15% | -$320 | ﹤0.01% | 2906 |
|
|
2024
Q2 | $1.85K | Sell |
93
-39
| -30% | -$760 | ﹤0.01% | 2832 |
|
|
2024
Q1 | $2.63K | Buy |
132
+64
| +94% | +$1.24K | ﹤0.01% | 2738 |
|
|
2023
Q4 | $1.52K | Sell |
68
-7
| -9% | -$145 | ﹤0.01% | 2863 |
|
|
2023
Q3 | $1.52K | Sell |
75
-35
| -32% | -$793 | ﹤0.01% | 2888 |
|
|
2023
Q2 | $2.81K | Hold |
110
| – | – | ﹤0.01% | 2645 |
|
|
2023
Q1 | $3.27K | Hold |
110
| – | – | ﹤0.01% | 2572 |
|
|
2022
Q4 | $2.98K | Hold |
110
| – | – | ﹤0.01% | 2530 |
|
|
2022
Q3 | $2K | Buy |
110
+12
| +12% | +$314 | ﹤0.01% | 2589 |
|
|
2022
Q2 | $3K | Hold |
98
| – | – | ﹤0.01% | 2419 |
|
|
2022
Q1 | $3K | Buy |
98
+32
| +48% | +$1.03K | ﹤0.01% | 2439 |
|
|
2021
Q4 | $2K | Hold |
66
| – | – | ﹤0.01% | 2658 |
|
|
2021
Q3 | $2K | Hold |
66
| – | – | ﹤0.01% | 2647 |
|
|
2021
Q2 | $2K | Hold |
66
| – | – | ﹤0.01% | 2526 |
|
|
2021
Q1 | $3K | Hold |
66
| – | – | ﹤0.01% | 2332 |
|
|
2020
Q4 | $3K | Hold |
66
| – | – | ﹤0.01% | 2171 |
|
|
2020
Q3 | $2K | Buy |
66
+31
| +89% | +$991 | ﹤0.01% | 2267 |
|
|
2020
Q2 | $1K | Sell |
35
-13
| -27% | -$376 | ﹤0.01% | 2287 |
|
|
2020
Q1 | $1K | Sell |
48
-2
| -4% | -$60 | ﹤0.01% | 2231 |
|
|
2019
Q4 | $2K | Hold |
50
| – | – | ﹤0.01% | 2174 |
|
|
2019
Q3 | $2K | Hold |
50
| – | – | ﹤0.01% | 2141 |
|
|
2019
Q2 | $2K | Hold |
50
| – | – | ﹤0.01% | 2055 |
|
|
2019
Q1 | $2K | Hold |
50
| – | – | ﹤0.01% | 2052 |
|
|
2018
Q4 | $2K | Hold |
50
| – | – | ﹤0.01% | 1838 |
|
|
2018
Q3 | $3K | Hold |
50
| – | – | ﹤0.01% | 1868 |
|
|
2018
Q2 | $2K | Sell |
50
-2
| -4% | -$106 | ﹤0.01% | 1812 |
|
|
2018
Q1 | $2K | Hold |
52
| – | – | ﹤0.01% | 1811 |
|
|
2017
Q4 | $2K | Hold |
52
| – | – | ﹤0.01% | 1820 |
|
|
2017
Q3 | $2K | Hold |
52
| – | – | ﹤0.01% | 1818 |
|
|
2017
Q2 | $2K | Hold |
52
| – | – | ﹤0.01% | 1844 |
|
|
2017
Q1 | $2K | Hold |
52
| – | – | ﹤0.01% | 1751 |
|
|
2016
Q4 | $2K | Buy |
+52
| New | +$1.86K | ﹤0.01% | 1599 |
|
Other funds holding AVNS
AC
VCM
VPM
Parallel Advisors's AVNS Position: Q1 2026 in Review
Parallel Advisors increased its Avanos Medical (AVNS) stake by 98% in Q1 2026, buying an estimated $835 and bringing the position to 125 shares worth $1.75K. The position accounts for ﹤0.01% of the portfolio, ranked #3418.
Parallel Advisors first reported a position in AVNS in Q4 2016 and has held it in 38 quarters since. The position peaked at $17.7K in Q1 2025. 257 funds tracked by Wall St. Rank hold AVNS as of Q1 2026.
- Parallel Advisors held 125 shares of Avanos Medical worth $1.75K as of Q1 2026.
- Parallel Advisors bought 62 Avanos Medical shares in Q1 2026, an estimated $835.
- Avanos Medical made up ﹤0.01% of Parallel Advisors's portfolio in Q1 2026, its #3418 holding.
- Parallel Advisors first reported a position in Avanos Medical in Q4 2016 and has held it in 38 quarters since.
- Parallel Advisors's Avanos Medical position peaked at $17.7K in Q1 2025.
- 257 funds tracked by Wall St. Rank held Avanos Medical as of Q1 2026.
Based on Parallel Advisors's 13F filing for Q1 2026, filed 7 May 2026.